Year: 2011
The GMO Register Entry G0451-01 provides significant details of the clinical trial.
Year: 2011
This is the final report on the malaria vaccine trial. The report details an overview of the clinical trial and the methodology and results of the trial.
Year: 2011
All documentation submitted in respect of this notification was taken into consideration by the EPA inspector in her report to the Board of the Agency.
Year: 2011
Consent Conditions issued to Professor Samuel McConkey, Royal College of Surgeons in Ireland, to carry out a clinical trial on patients to assess the safety and immunogenicity of a new malaria vaccine, using two Genetically Modified Micro-Organisms (GMMs), at Beaumont Hospital in Dublin, from September 2011 to December 2012.
Year: 2011
There is a statutory requirement under Part A of the 5th Schedule of the Genetically Modified Organisms (Contained Use) Regulations, 2001 to 2010, to provide details of any biological committees or subcommittees.
Year: 2011
These schedules are an extract from the Waste Management Act 1996 as amended, detailing the disposal and recovery activities that require a waste licence.
Year: 2011
Additional information to be submitted with a notification for the contained use of a Class 1 / 2 GMM under the GMO (Contained Use) Regulations 2001 to 2010. This covers information required under Part A of the Fifth Schedule and further information for the assessment of the notification.
Year: 2011
Additional information to be submitted with a notification for the contained use of a GMO (GM Aminal/ GM Plant) under the GMO (Contained Use) Regulations 2001 to 2010. This covers information required under Part I of the Seventh Schedule and further information for the assessment of the notification. Please view Guidelines for those who plan to work with GM animals / GM plants.
Year: 2010
All documentation submitted in respect of this notification was taken into consideration by the EPA inspector in her report to the Board of the Agency.
Year: 2010
Consent Conditions G0362-01 issued to Applied Genetics Technologies Corporation, USA, to carry out a clinical trial on patients suffering from alpha-1 antitrypsin deficiency, using a Genetically Modified Micro-Organism (GMM). This trial did not proceed.
Year: 2010
The GMO Register Entry provides significant details of the clinical trial.
Year: 2010
BAT Guidance Note for the Production of Paper Pulp. Paper & Board
Year: 2010
BAT Guidance Note for the Initial Melting and Production of Iron & Steel Sector
Year: 2010
BAT Guidance Note for the Manufacture of Integrated Circuits
Year: 2010
A guide to the administrative requirements for the import and export of sealed radioactive sources.
Year: 2010
Anyone who makes a valid objection to the granting of a licence from the Environmental Protection Agency (EPA) can request an oral hearing. The EPA has absolute discretion to hold an oral hearing and may decide to hold an oral hearing regardless of whether or not a request has been made.
Year: 2009
This document should be used to identify the Conclusions on BAT from the Energy Efficiency reference document (BREF) applicable for a given proposed licence application.
Year: 2009
Year: 2008
BAT Guidance Note on Best Available Techniques for the Pesticides, Pharmaceuticals & Speciality Organic Chemicals Sector.
Year: 2008
BAT Guidance Note on Best Available Techniques for Solvent Use in Coating, Cleaning & Degreasing.
